DCVMN 26th AGM Boosts Global Vaccine Resilience in Bali

Published: 2025-10-31

DCVMN 26th AGM Boosts Global Vaccine Resilience in Bali

Industry Insights from Next Move Strategy Consulting

Amid persistent supply chain vulnerabilities and geopolitical shifts, the 26th DCVMN Annual General Meeting (AGM) opens in Bali as a cornerstone event for global vaccine security. Co-hosted by PT Bio Farma (Persero) at The Meru, Sanur, from October 29 to 31, 2025, the gathering unites more than 420 delegates from 46 vaccine producers in 17 developing nations, joined by WHO, UNICEF, Gavi, CEPI, PATH, CHAI, the Gates Foundation, regulators, academics, and health leaders. Centered on the theme “Advancing Innovation and Building a Resilient Vaccine Ecosystem for a Safer World,” discussions target enhanced production, faster technology transfer, and broader access to safe, quality-assured, cost-effective vaccines.

A Unified Push for Decentralized Vaccine Strength

The COVID-19 crisis revealed risks in concentrated production models, spurring DCVMN’s focus on regional empowerment. In a virtual keynote, Indonesia’s Minister of Health Budi Gunadi Sadikin praised the network’s pandemic contributions and its role in elevating developing countries as key players in vaccine evolution.

“Through member commitment, DCVMN has transformed global vaccine manufacturing—scaling capacity, embracing new technologies, and building robust partnerships,” he noted, stressing that local production strengthens supply chain and delivers lasting value.

Deputy Minister of Health Dante Saksono Harbuwono highlighted collaborative R&D and equity, citing Indonesia’s Vaccine Collaboration Center and the Indonesia-China Joint Research and Development on Vaccines and Genomics Secretariat in Kura-Kura, Bali.

“No nation stands alone; DCVMN fosters innovation and equitable vaccine access,” Dante declared, adding that Indonesia advances health independence via the center, Tsinghua University partnership, and TB/malaria clinical trials.

Key Focus Areas at a Glance:

  • Production Scaling through accelerated technology transfer and alliances with WHO, UNICEF, and Gavi.

  • R&D Ecosystems anchored by initiatives like Bali’s joint secretariat and global trials.

  • Access Strategies addressing rigorous WHO prequalification and shrinking donor support.

  • Digital & AI Adoption to streamline manufacturing and distribution.    

  • Shared Accountability Framework balancing risks and investments across partners.

Bio Farma: Powering Global Immunization

Delivering to over 150 countries with 12 WHO-prequalified products, Bio Farma supplies UNICEF’s core polio vaccines for eradication campaigns. President Director Shadiq Akasya called for multilateral dialogue to sustain industry health alongside public protection.

“We require joint solutions with WHO, Gavi, CEPI, and donors to protect viability and health outcomes,” Shadiq urged, advocating a shared responsibility model amid stringent regulations and funding gaps.

The AGM serves Bio Farma as a platform to deepen ties and promote self-reliance in developing markets.

DCVMN CEO Rajinder Suri stressed readiness for emerging threats.

“We stand prepared with CEPI and WHO, applying pandemic lessons—AI and digital tools are conference priorities,” Suri said, noting collective action across sectors to secure a healthier future.

Impact on the Vaccines Market: Next Move Strategy Consulting’s View

The DCVMN AGM strengthens the global Vaccine Market ecosystem by promoting regional manufacturing capacity, technology transfer, and self-reliance in developing countries. The focus on shared responsibility—distributing risks, costs, and sustainability efforts—addresses challenges like declining donor funding and stringent WHO prequalification. With emphasis on AI, digital transformation, and collaborative R&D including genomics, the forum supports industrial viability and equitable access to safe, affordable vaccines worldwide.

Forging a Safer, Self-Reliant Vaccine Horizon

Against rising health risks, the DCVMN AGM charts a collaborative path where innovation, equity, and shared duty ensure vaccines protect populations worldwide—sustainably and without borders.

Source: ANTARA News 

Prepared by: Next Move Strategy Consulting

About the Author

Nitrishna Sonowal is a dynamic SEO Executive and Content Writer with 3+ years in digital marketing. She blends data-driven SEO strategies with creative storytelling to craft content that boosts engagement, drives traffic, and strengthens brand presence. Experienced in keyword research, on-page optimization, and content strategy, she delivers measurable results for clients across industries. Passionate about digital trends, she thrives on turning insights into impactful campaigns. Outside work, she enjoys dancing, baking, and exploring new destinations.

About the Reviewer

Sanyukta Deb is an accomplished Content Writer and Digital Marketing Strategist with extensive expertise in content strategy, SEO, and audience engagement. She specializes in building strong brand visibility through data-driven campaigns and impactful, value-added researched content. With a passion for creativity and innovation, she blends strategic thinking with design and communication to craft meaningful digital experiences. Over the years, she has contributed cross-functional marketing projects, driving measurable impact and audience engagement.

Add Comment

Please Enter Full Name

Please Enter Valid Email ID

Please enter comment

Share with Peers

  • Facebook
  • Twitter
  • Linkedin
  • Whatsapp
  • Mail
Our Clients

This website uses cookies to ensure you get the best experience on our website. Learn more